Verastem, Inc.
جودة البيانات: 100%
VSTM
NASDAQ
Manufacturing
Chemicals
KWD 5.31
▼
KWD 0.28
(-5.01%)
القيمة السوقية: 494.07 M
السعر
KWD 5.63
القيمة السوقية
494.07 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—
Quick Summary
النقاط الرئيسية
Revenue grew 96.99% annually over 5 years — strong growth
Negative free cash flow of -137.54 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 112.15%
Capital efficient — spends only 0.09% of revenue on capex
النمو
Revenue Growth (5Y)
96.99%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)209.14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-2040.63%
أقل من متوسط القطاع (-54.01%)
ROIC-102.19%
Net Margin-677.59%
Op. Margin-550.33%
الأمان
Debt / Equity
N/A
Current Ratio2.58
Interest Coverage-149.50
التقييم
PE (TTM|NTM)
-2.36 | -4.49
أقل من متوسط القطاع (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1385 نظير)| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -2.4 | -1.5 |
| P/B | — | 1.6 |
| ROE % | -2040.6 | -54.0 |
| Net Margin % | -677.6 | -41.5 |
| Rev Growth 5Y % | 97.0 | 1.8 |
| D/E | — | 0.3 |
السعر المستهدف للمحللين
8 محللين
Buy
الحالي
KWD 5.31
المستهدف
KWD 16.38
KWD 14.00
KWD 16.00
KWD 19.00
التوقعات
مكرر الربحية المستقبلي
-4.49
ربحية السهم المستقبلية
-KWD 1.18
الإيرادات المقدّرة
199.75 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2027 |
-KWD 1.18
-KWD 1.35 – -KWD 0.90
|
199.75 M | 3 |
| FY2026 |
-KWD 1.71
-KWD 1.93 – -KWD 1.55
|
117.27 M | 3 |
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| 2026 Q2 |
-KWD 0.45
-KWD 0.52 – -KWD 0.41
|
26.58 M | 3 |
| 2026 Q1 |
-KWD 0.47
-KWD 0.50 – -KWD 0.44
|
21.84 M | 3 |
مفاجآت الأرباح
آخر 4 أرباع
| الربع | EPS المقدر | EPS الفعلي | المفاجأة |
|---|---|---|---|
| Q42025 | -KWD 0.50 | -KWD 0.46 | +7.5% |
| Q32025 | -KWD 0.61 | -KWD 0.54 | +11.0% |
| Q22025 | -KWD 0.75 | -KWD 0.63 | +15.4% |
| Q12025 | -KWD 0.78 | -KWD 0.79 | -1.9% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 209.14% | Revenue Growth (3Y) | 245.08% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 96.99% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 30.91 M | Net Income (TTM) | -209.47 M |
| ROE | -2040.63% | ROA | -112.28% |
| Gross Margin | N/A | Operating Margin | -550.33% |
| Net Margin | -677.59% | Free Cash Flow (TTM) | -137.54 M |
| ROIC | -102.19% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.58 |
| Interest Coverage | -149.50 | Asset Turnover | 0.17 |
| Working Capital | 94.34 M | Tangible Book Value | -32.23 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.36 | Forward P/E | -4.49 |
| P/B Ratio | N/A | P/S Ratio | 15.98 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.47 | Fwd Earnings Yield | N/A |
| FCF Yield | -27.84% | ||
| Market Cap | 494.07 M | Enterprise Value | 397.09 M |
| Per Share | |||
| EPS (Diluted TTM) | -3.02 | Revenue / Share | 0.35 |
| FCF / Share | -1.57 | OCF / Share | -1.57 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.09% | FCF Conversion | 65.66% |
| SBC-Adj. FCF | -148.30 M | Growth Momentum | 112.15 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 30.91 M | 10.00 M | 2.60 M | 2.60 M | 2.05 M |
| Net Income | -209.47 M | -130.64 M | -87.37 M | -73.81 M | -71.20 M |
| EPS (Diluted) | -3.02 | -3.66 | -3.93 | -0.38 | -0.41 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -170.13 M | -114.96 M | -92.08 M | -72.94 M | -61.41 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 114.60 M | 81.33 M | 61.36 M | 50.56 M | 39.35 M |
| SG&A Expenses | 81.15 M | 43.62 M | 30.73 M | 24.98 M | 24.12 M |
| D&A | — | — | — | — | — |
| Interest Expense | 1.14 M | 4.56 M | 4.14 M | 2.14 M | 9.97 M |
| Income Tax | 185,000.0 | 185,000.0 | — | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 246.44 M | 101.54 M | 149.72 M | 95.05 M | 108.66 M |
| Total Liabilities | 189.25 M | 130.43 M | 71.19 M | 47.66 M | 21.10 M |
| Shareholders' Equity | 57.20 M | -28.89 M | 57.37 M | 47.39 M | 87.56 M |
| Total Debt | 40.72 M | 40.72 M | 40.09 M | 24.53 M | — |
| Cash & Equivalents | 204.99 M | 88.82 M | 77.91 M | 74.93 M | 21.25 M |
| Current Assets | 223.41 M | 94.96 M | 143.68 M | 92.87 M | 105.74 M |
| Current Liabilities | 72.27 M | 30.97 M | 26.38 M | 21.66 M | 18.59 M |
{"event":"ticker_viewed","properties":{"ticker":"VSTM","listing_kind":"stock","pathname":"/stocks/vstm","exchange":"NASDAQ","country":"US"}}